|
Click
Here: Registration
Now Open
June
22, 2010
Symposium: 9:00 am – 5:00 pm
Networking Reception & Banquet: 5:30 pm
Yale University
Woolsey
Hall, Presidents Room
Our
Exciting Agenda Has Been Posted - Check It Out!
The Symposium on U.S.-China Life
Science Industry Collaborations is designed to introduce biotech
and pharma companies to the opportunities afforded for research and
development and commercialization
partnering by China.
Multinational pharma companies started their China strategy in the
70s, and now have established significant manufacturing, R&D,
and commercialization capabilities. Their confidence in
China is highlighted by GlaxoSmithKline’s decision to move its
global neuroscience R&D center to Shanghai. Smaller and
early stage biotech companies have heard about the opportunities
provided by Chinese CROs and CMOs, and are feeling the necessity
to correctly utilize the resources in China to remain competitive.
China’s robust market growth, improved R&D and outsourcing
capabilities, and pipeline of novel molecules open the doors
to strategic partnerships.
This one day meeting is an opportunity to get an overview of the
Chinese industry landscape, hear case studies on successful
relationships that have been established and get some early ideas
on how to go about setting up a strategic relationship with a
Chinese company.
Click
Here: Registration
Now Open
Speakers include:
* Leaders of the China National Center for
Biotechnology Development
* Representatives from two Bioscience Parks in
China
* CEO of the largest Vaccine Company in China
* Executives of Chinese biotech and pharma
companies
* Executives from China’s leading CRO
*
Leaders from Yale University's technology transfer office
* Connecticut Economic Development Commissioner
* CEO of CURE (Connecticut State bioscience
organization)
* Partner from Wiggin and Dana (Connecticut law
firm)
At the meeting, we will cover:
* An overview of the Chinese Biotech Industry
* Introduction on Chinese vaccine industry and
development trend
* Chinese Bioscience Parks
* Collaborations between business and academia.
American and China
* Case studies
Click
Here: Registration
Now Open
“China’s
pharmaceutical market is expected to continue to grow at a
20+% pace annually (global growth at 4-7%), and contribute
21% of overall global growth through 2013. China will
become the world's third-largest prescription drug market
in 2011.”
Source: IMS Health
“Partnering has become a significant component of
China’s burgeoning biopharma industry. The number
of partnering deals grew by 41% in 2009, with
co-development deals the fastest growing segment.
This has been driven by China’s robust pipeline of over
2,000 novel molecules with nearly 200 in clinical
development.”
Source: ChinaBio |
Admission
$75*
$50* for CURE/NYBA/MassBio members and Yale Community
$30* for students and postdocs (includes lunch)
*Plus service charge of $3
Networking
Reception & Banquet at Yale June 22
$100 per person
Click
Here: Registration
Now Open
Organizers
CURE (Connecticut United for
Research Excellence, Inc.
China National Center for Biotechnology Development (CNCBD)
Columbus Growth Partners (CGP)
Yale University
|
